Evaluation of the effect of misoprostol on cesarean bleeding
Phase 3
Recruiting
- Conditions
- The amount of bleeding from a cesarean section.
- Registration Number
- IRCT20200501047257N1
- Lead Sponsor
- Mazandaran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 180
Inclusion Criteria
Patients between the ages of 18 and 40
Candidates for cesarean section
Gestational age between 37 and 40 weeks
Candidates for Spinal anesthesia
Written consent from the patient
Single pregnancy
Low transverse uterine incision
Exclusion Criteria
History of PPH (postpartum hemorrhage)
Placenta previa and acarta
Liver or kidney disease
Eclampsia and preeclampsia
Epilepsy
Height below 155 cm
Obesity (BMI> 40) ( BMI = Body mass index)
Infant weight over 4 kg
Polyhydramnios (increased amniotic fluid)
Patients received Anti-coagulation drugs
Patients with heart and lung problems and underlying diseases such as diabetes, high blood pressure (140/90 mm Hg), chronic anemia, coagulation disorders and immunodeficiency
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bleeding during cesarean section. Timepoint: Bleeding is removed during surgery and after surgery. Method of measurement: The amount of blood lost in each group at the end of the operation, based on the amount of blood in the suction and the estimated blood volume absorbed by each gauze and long gauze with the scales before and after The operation is weighed and the amount of clot excreted from the vagina after uterine massage is calculated at the end of the operation and will be recorded in the desired checklist.
- Secondary Outcome Measures
Name Time Method